First Manhattan’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

First Manhattan’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19,882	Closed	-$1.81M	–	1419
2019 Q2	$1.81M	Sell	19,882 -28,008	-58%	-$3.41M	0.01%	347
2019 Q1	$7.07M	Sell	47,890 -957	-2%	-$185K	0.04%	199
2018 Q4	$7.69M	Hold	48,847	–	–	0.05%	188
2018 Q3	$12M	Buy	+48,847	New	+$11.6M	0.06%	169

Other funds holding DMK

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Manhattan's DMK Position: Q3 2019 in Review

First Manhattan sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2019, closing a stake of 19,882 shares — an estimated $1.81M sold.

First Manhattan first reported a position in DMK in Q3 2018 and held it in 4 quarters. The position peaked at $12M in Q3 2018. 50 funds tracked by Wall St. Rank hold DMK as of Q3 2019.

First Manhattan reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2019 after selling out during the quarter.
First Manhattan sold 19,882 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2019, an estimated $1.81M.
First Manhattan first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2018 and held it in 4 quarters.
First Manhattan's DMK Pharmaceuticals Corporation Common Stock position peaked at $12M in Q3 2018.
50 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2019.

Based on First Manhattan's 13F filing for Q3 2019, filed 13 Nov 2019.